![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
Since the identification of the nonpeptide tachykinin antagonists CP–96345 (Pfizer) and SR-48968 (Sanofi), interest in this area of research has increased markedly with several pharmaceutical companies actively patenting structures for a range of therapeutic applications. This review surveys the activity of several pharmaceutical companies in the patent literature during January through December 1995.